Intrathecal Dexmedetomidine Analgesia After Cesarean Delivery: A Feasibility Trial
( Can J Anesth/J Can Anesth. 2024;71:161–162. doi:10.1007/s12630-023-02630-z) A small feasibility study comparing intrathecal dexmedetomidine given for pain after cesarean delivery to the standard treatment found that dexmedetomidine did not control pain as well as the standard treatment of bupivacaine with combined morphine and fentanyl.
Authors
- Christina Lamontagne (ORCID: https://orcid.org/0000-0001-8176-6996)
- Sandra Lesage
- Anne-Marie Ouellet (ORCID: https://orcid.org/0009-0007-6607-5098)
- C. Crochetière
Institutions
- Centre Hospitalier Universitaire Sainte-Justine (CA)
Publication Details
- Journal
- Obstetric Anesthesia Digest
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1097/01.aoa.0001080300.44108.23
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00